Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Spruce Biosciences, Inc. Common Stock (SPRB)

Pharmaceutical Preparations

https://www.sprucebiosciences.com

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

611 GATEWAY BOULEVARD, SUITE 740
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/09/2020

Market Cap

18,928,982

Shares Outstanding

40,710,000

Weighted SO

40,710,692

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

INZY --.--%

DAWN --.--%

TERN --.--%

ELDN --.--%

HOOK --.--%

XFOR --.--%

ABOS --.--%

VECT --.--%

Beta

2.4180

Last Div

0.0000

Range

0.411-5.95

Chg

0.0184

Avg Vol

508154

Mkt Cap

18928982

Exch

NASDAQ

Country

US

Phone

415 655 4168

DCF Diff

0.0798

DCF

0.7783

Div Yield

0.0000

P/S

1.9775

EV Multiple

0.9919

P/FV

0.3188

Div Yield %

0.0000

P/E

-0.4376

PEG

-0.0124

Payout

0.0000

Current Ratio

5.1741

Quick Ratio

5.1741

Cash Ratio

4.8781

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

4148.8333

CCC

-4148.8333

Gross Margin

0.9937

Op Margin

-4.9615

Pretax Margin

-4.5038

Net Margin

-4.5038

Eff Tax Rate

0.0234

ROA

-0.5708

ROE

-0.5994

ROCE

-0.7756

NI/EBT

1.0000

EBT/EBIT

0.9078

EBIT/Rev

-4.9615

Debt Ratio

0.0372

D/E

0.0475

LT Debt/Cap

0.0154

Total Debt/Cap

0.0454

Int Coverage

-47491.0000

CF/Debt

-17.6181

Equity Multi

1.2763

Rec Turnover

0.0000

Pay Turnover

0.0880

Inv Turnover

0.0000

FA Turnover

9.0302

Asset Turnover

0.1267

OCF/Share

-1.2036

FCF/Share

-1.2037

Cash/Share

1.6928

OCF/Sales

-5.1757

FCF/OCF

1.0001

CF Coverage

-17.6181

ST Coverage

-26.2266

CapEx Coverage

-7077.4286

Div&CapEx Cov

-7077.4286

P/BV

0.3188

P/B

0.3188

P/S

1.9775

P/E

-0.4376

P/FCF

-0.3820

P/OCF

-0.3808

P/CF

-0.3808

PEG

-0.0124

P/S

1.9775

EV Multiple

0.9919

P/FV

0.3188

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation